Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. - ROEverified

INO

Price:

$1.115

Market Cap:

$59.75M

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen. This innovative approach is supported by its CELLECTRA smart device technology, which efficiently delivers the DNA plasmids. Inovio is actively engaged in and planning clinical trials for its DNA medicines across a wide array of conditions. ...[Read more]

Industry

Biotechnology

IPO Date

1998-12-08

Stock Exchange

NASDAQ

Ticker

INO

The ROE as of June 2026 (TTM) for Inovio Pharmaceuticals, Inc. (INO) is -666.47%

According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -666.47%. This represents a change of -1445.40% compared to the average of 49.54% of the last 4 quarters.

Inovio Pharmaceuticals, Inc. (INO) Historical ROE (quarterly & annually)

How has INO ROE performed in the past?

The mean historical ROE of Inovio Pharmaceuticals, Inc. over the last ten years is -457.01%. The current -666.47% ROE has changed 45.83% with respect to the historical average. Over the past ten years (40 quarters), INO's ROE was at its highest in in the September 2025 quarter at 589.34%. The ROE was at its lowest in in the December 2019 quarter at -1096.39%.

Quarterly (TTM)
Annual

Average

-457.01%

Median

-113.34%

Minimum

-3474.70%

Maximum

-36.09%

Inovio Pharmaceuticals, Inc. (INO) ROE by Quarter and Year

Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.02%

Maximum Annual ROE = -36.09%

Minimum Annual Increase = -98.96%

Minimum Annual ROE = -3474.70%

Quarterly (TTM)
Annual
YearROEChange
2025-352.53%125.16%
2024-156.57%35.98%
2023-115.14%-8.50%
2022-125.84%65.63%
2021-75.98%110.54%
2020-36.09%-98.96%
2019-3474.70%3.02%
2018-111.54%80.06%
2017-61.95%3.56%
2016-59.81%260.04%

Inovio Pharmaceuticals, Inc. (INO) Average ROE

How has INO ROE performed in the past?

The current ROE of Inovio Pharmaceuticals, Inc. (INO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-208.08%

5-year avg

-165.21%

10-year avg

-457.01%

Inovio Pharmaceuticals, Inc. (INO) ROE vs. Peers

How is INO’s ROE compared to its peers?

Inovio Pharmaceuticals, Inc.’s ROE is greater than Acumen Pharmaceuticals, Inc. (-123.07%), less than Opus Genetics, Inc. (6.07%), greater than Agenus Inc. (-23.05%), greater than Seer, Inc. (-26.58%), less than Spero Therapeutics, Inc. (35.58%), greater than Fate Therapeutics, Inc. (-58.89%), greater than Seres Therapeutics, Inc. (-127.30%), greater than VistaGen Therapeutics, Inc. (-133.02%), greater than Alector, Inc. (-295.17%), greater than Actuate Therapeutics Inc (-430.93%),

Build a custom stock screener for Inovio Pharmaceuticals, Inc. (INO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inovio Pharmaceuticals, Inc. (INO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Inovio Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Inovio Pharmaceuticals, Inc. (INO)?

What is the highest ROE for Inovio Pharmaceuticals, Inc. (INO)?

What is the 3-year average ROE for Inovio Pharmaceuticals, Inc. (INO)?

What is the 5-year average ROE for Inovio Pharmaceuticals, Inc. (INO)?

How does the current ROE for Inovio Pharmaceuticals, Inc. (INO) compare to its historical average?